Cargando…
Identification of a novel small-molecule Keap1–Nrf2 PPI inhibitor with cytoprotective effects on LPS-induced cardiomyopathy
A new Keap1–Nrf2 protein–protein interaction (PPI) inhibitor ZJ01 was identified from our compound library by fluorescence polarization assay, surface plasmon resonance, molecular docking and molecular dynamics simulation. ZJ01 could in vitro trigger Nrf2 nuclear translocation, subsequently resultin...
Autores principales: | Jiang, Cheng-Shi, Zhuang, Chun-Lin, Zhu, Kongkai, Zhang, Juan, Muehlmann, Luis Alexandre, Figueiró Longo, João Paulo, Azevedo, Ricardo Bentes, Zhang, Wen, Meng, Ning, Zhang, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009974/ https://www.ncbi.nlm.nih.gov/pubmed/29693453 http://dx.doi.org/10.1080/14756366.2018.1461856 |
Ejemplares similares
-
An updated overview on the development of new photosensitizers for anticancer photodynamic therapy
por: Zhang, Juan, et al.
Publicado: (2018) -
Editorial: Nanomedicine in Cancer Targeting and Therapy
por: Longo, João Paulo Figueiró, et al.
Publicado: (2021) -
Aluminum–phthalocyanine chloride associated to poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as a new third-generation photosensitizer for anticancer photodynamic therapy
por: Muehlmann, Luis Alexandre, et al.
Publicado: (2014) -
How has nanomedical innovation contributed to the COVID-19 vaccine development?
por: Figueiró Longo, João Paulo, et al.
Publicado: (2021) -
Application of Nanomedicine in Immunotherapy: Recent Advances and Prospects
por: Longo, João Paulo Figueiró, et al.
Publicado: (2023)